SCI Abstract

search
+
Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK
Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK
Patients with higher-risk myelodysplastic syndromes (MDS) face considerable challenges in disease management and often req...
Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia
Diversity in Oncology Clinical Trials: Current Landscape for Industry-Sponsored Clinical Trials in Asia
There has been a growing recognition on the importance of diversity in clinical trials. Existing research has highlighted ...
Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely?
Adjuvant CDK4/6 Inhibitors for Early Breast Cancer: How to Choose Wisely?
Assuming that ribociclib will be approved in the adjuvant setting on the basis of the recent findings from NATALEE, some p...
From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa
From Incidence to Intervention: A Comprehensive Look at Breast Cancer in South Africa
The formidable impact of breast cancer extends globally, with South Africa facing pronounced challenges, including signifi...
Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?
Wolff AC, et al. HER2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Cli...
Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer
Repotrectinib’s Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer
In this work, we report on a clinically significant response of meningeal carcinomatosis to repotrectinib in a woman with ...
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
It is unclear how soon after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection it is safe to resume s...
Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma
Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma
Patients with follicular lymphoma (FL) receiving third-line or later (3L +) therapy have long survival, which can ma...
A Meta-analysis of Surgical Outcomes of T4a and Infranotch T4b Oral Cancers
A Meta-analysis of Surgical Outcomes of T4a and Infranotch T4b Oral Cancers
To determine the overall surgical outcomes of infranotch T4b oral cancers and compare them with T4a oral cancers. PubMed, ...
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast
Shared decision-making involves patients engaging with their physicians to make informed decisions regarding treatment sel...
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer
The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer
Deleterious germline mutations in BRCA1 and BRCA2 genes are associated with a high risk of breast and ovarian cancer. In m...
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists
EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists
This podcast, for healthcare professionals (HCPs), patients, and patient advocates, is a discussion among a panel of two p...
Recent Advances in Gynecological Malignancies: Focus on ASCO 2023
Recent Advances in Gynecological Malignancies: Focus on ASCO 2023
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estim...
Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer
Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer
Many patients with human epidermal growth factor receptor-2-positive metastatic breast cancer (HER2+ mBC) require su...
Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast
Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast
This podcast highlights the importance of genetic testing in patients with metastatic breast cancer, with a specific focus...
RETRACTED ARTICLE: Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors
RETRACTED ARTICLE: Tarsoconjunctival Granulation Tissue Formation Associated with EGFR Inhibitors
Open Access This article is licensed under a Creative Commons Attribution-NonCommerci...
French Retrospective Database Analysis of Patient Characteristics and Treatment Patterns in Patients with R/R FLT3-Mutated AML: A Registry-Based Cohort Study
French Retrospective Database Analysis of Patient Characteristics and Treatment Patterns in Patients with R/R FLT3-Mutated AML: A Registry-Based Cohort Study
There is a dearth of evidence to document treatment of FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid le...
Small-Cell Carcinoma of the Prostate – Challenges of Diagnosis and Treatment: A Next of Kin and Physician Perspective Piece
Small-Cell Carcinoma of the Prostate – Challenges of Diagnosis and Treatment: A Next of Kin and Physician Perspective Piece
This article was co-authored by a patient’s relative describing their experiences of receiving a diagnosis and subse...
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
The immunomodulatory impact of corticosteroids and concurrent chemotherapy is poorly understood within triple-negative bre...
Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021
Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021
Biomarker testing is increasingly crucial for patients with early-stage non-small cell lung cancer (eNSCLC). We explored b...
Neoadjuvant Doxorubicin-Paclitaxel Combined Chemotherapy in Patients with Inoperable Stage III Breast Cancer: A Retrospective Cohort Study with 10 Years of Follow-Up in Vietnam
Neoadjuvant Doxorubicin-Paclitaxel Combined Chemotherapy in Patients with Inoperable Stage III Breast Cancer: A Retrospective Cohort Study with 10 Years of Follow-Up in Vietnam
The combination of doxorubicin and paclitaxel (AP) is widely used in our country for the neoadjuvant treatment of breast c...
Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast
Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A Podcast
In this plain language podcast, highlights from the European Society for Medical Oncology (ESMO) Congress are discussed fo...
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple Myeloma
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple Myeloma
Extrapolating long-term overall survival (OS) from shorter-term clinical trial data is key to health technology assessment...
Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews
Patient Perceptions of CAR-T Therapy in the USA: Findings from In-Depth Interviews
Chimeric antigen receptor-T cell (CAR-T) therapy has revolutionized advanced blood cancer treatment. However, preparation,...
Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial
Diagnostic and Treatment Obstacles in Acute Myeloid Leukemia: Social, Operational, and Financial
Acute myeloid leukemia (AML) can affect individuals of all ages, but is more common in older adults. It has been estimated...
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma
Ciltacabtagene autoleucel (cilta-cel), is a B-cell maturation antigen-directed, genetically modified autologous chimeric a...
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance
We evaluated real-world outcomes in patients with advanced ovarian cancer (AOC) based on their cumulative risk profile and...
The Future of Breast Cancer Research in the Survivorship Field
The Future of Breast Cancer Research in the Survivorship Field
Prevalence of survivors of breast cancer has been steadily increasing in the last 20 years. Currently, more than ...
Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
The optimal approach to locally advanced head and neck squamous cell carcinoma (LAHNSCC) treatment remains controversial. ...
Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review
Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review
Breast cancer is the most frequently diagnosed malignancy in patients worldwide and the main cause of cancer-related death...
Load More
format_indent_increase